Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
LIVN vs ITGR: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
LIVN Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 6–4 Matrix Metrics)
LIVN Overall Winner
6-Pillar Tally: LIVN 6 – 0 ITGR
Matrix Metrics: LIVN 6 – 4 ITGR
As of Nov 19, 2026, LivaNova PLC (LIVN) is the stronger overall head-to-head candidate over Integer Holdings Corporation (ITGR) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). LIVN carries a Unified Composite Score of 38.5/100 (SELL) at $92.07 (19.5x Forward P/E, 14.3% operating margin), whereas ITGR carries 65.5/100 (BUY) at $126.97 (18.5x Forward P/E, 9.8% operating margin).
- Composite vs. Pillar Nuance: While ITGR currently prints a higher short-term Unified Composite Score (65.5/100 BUY vs. LIVN 38.5/100 SELL), LIVN captures the overall institutional head-to-head verdict (6–4 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (14.3% vs. 9.8% operating margin) and revenue trajectory (+9.9% vs. -3.9% YoY).
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About LIVN vs ITGR
LIVN
Head-to-Head Winner
LivaNova PLC Ordinary Shares
$92.07
-2.61% 1D
Market Cap
$5.1B
TTM Revenue
$1.51B
Forward P/E
19.5x
Beta / 30D Vol
0.98β · 67% Vol
Unified Composite Score
38.5
SELL
Tech 23.0
Fund 40.0
Flow 70.0
Mom 21.1
Weinstein Technical Phase
Markup · Hold / add on dips
ITGR
Integer Holdings Corporation
$126.97
+0.21% 1D
Market Cap
$4.3B
TTM Revenue
$1.83B
Forward P/E
18.5x
Beta / 30D Vol
0.53β · 2% Vol
Unified Composite Score
65.5
BUY
Tech 59.0
Fund 59.0
Flow 60.0
Mom 58.9
Weinstein Technical Phase
Neutral · Hold
6-Pillar Scorecard Institutional Category Breakdown (LIVN 6 – 0 ITGR)
1. Valuation Multiples
LIVN
Forward P/E
19.5x
18.5x
Trailing P/E
26.5x
42.5x
PEG Ratio
0.93x
3.06x
EV / Revenue
3.2x
3.1x
2. Growth & Scale
LIVN
Revenue Growth (YoY)
+9.9%
-3.9%
Earnings Growth (YoY)
-78.2%
-61.3%
TTM Revenue (USD)
$1.51B
$1.83B
Market Cap
$5.1B
$4.3B
3. Profitability & Quality
LIVN
Gross Margin
67.6%
25.1%
Operating Margin
14.3%
9.8%
Net Profit Margin
13.0%
5.7%
Return on Equity (ROE)
15.5%
6.0%
4. Balance Sheet & Cash Flow
LIVN
Cash Generation (TTM)
$129M
$83M
Cash Flow Margin
8.6%
4.5%
Net Cash / Leverage
$206M Net Cash
$1.33B Net Debt (0.78x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
LIVN
Options Structure Phase
CONSOLIDATION
CONSOLIDATION
Current IV / %ile
36.9% (11th %ile)
0.7% (<1st %ile)
Put/Call OI Skew
N/A
0.01x (Call-Skewed)
OBV Trend / Tech Phase
NEUTRAL · Markup
NEUTRAL · Neutral
6. R&D & Supply-Chain Moat
LIVN
OpEx & R&D Intensity
53.3% of Rev ($803M)
15.3% of Rev ($279M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Medical Devices Operator
Medical Devices Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: LIVN (6) vs ITGR (4)| Institutional Metric | LIVN | ITGR | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $5.1B | $4.3B | LIVN | |
| Trailing P/E Ratio | 26.5x | 42.5x | LIVN | |
| Forward P/E Ratio | 19.5x | 18.5x | ITGR | |
| Revenue Growth (YoY) | +9.9% | -3.9% | LIVN | |
| Operating Margin (TTM) | 14.3% | 9.8% | LIVN | |
| Net Profit Margin | 13.0% | 5.7% | LIVN | |
| Return on Equity (ROE) | 15.5% | 6.0% | LIVN | |
| 52-Week Range Position | 84% ($52–$99) | 91% ($67–$133) | ITGR | |
| Beta / 30D Volatility | 0.98β · 67% Vol | 0.53β · 2% Vol | ITGR | |
| Unified Institutional Score | 38.5 / 100 (SELL) | 65.5 / 100 (BUY) | ITGR | |
| Trailing 12M Revenue (USD) | $1.51B | $1.83B | Scale | |
| Gross Profit Margin (TTM) | 67.6% | 25.1% | Quality | |
| PEG Ratio & EV / Revenue | 0.93x PEG · 3.2x EV/Rev | 3.06x PEG · 3.1x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $129M ($206M Net Cash) | $83M ($1.33B Net Debt (0.78x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
LIVN +18.94 pp
3M Horizon
LIVN +14.25 pp
6M Horizon
ITGR +13.14 pp
1Y Horizon
ITGR +15.88 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | LIVN Revenue | ITGR Revenue | LIVN Op. Margin | ITGR Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $1.11B | $1.22B | -22.4% | 12.8% | ITGR |
| FY2019 | $1.08B | $1.26B | -15.8% | 12.5% | ITGR |
| FY2020 | $930M | $1.07B | -29.3% | 11.2% | ITGR |
| FY2021 | $1.04B | $1.22B | -0.1% | 11.1% | ITGR |
| FY2022 | $1.02B | $1.33B | -7.5% | 8.5% | ITGR |
| FY2023 | $1.15B | $1.56B | -5.9% | 10.5% | ITGR |
| FY2024 | $1.25B | $1.72B | 10.3% | 12.1% | ITGR |
| FY2025 | $1.39B | $1.85B | 14.4% | 11.9% | LIVN |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
LIVN
CONSOLIDATION
Current IV
36.9%
IV Percentile
11th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact LIVN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
ITGR
CONSOLIDATION
Current IV
0.7%
IV Percentile
<1st %ile
Put/Call OI Skew
0.01x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact ITGR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
LIVN Moat Profile
Cyclical / Execution-Driven Positioning
Medical Devices Operator
OpEx & R&D Reinvestment
53.3% of Rev ($803M)
90D Engineering Disclosures
0 Published
ITGR Moat Profile
Cyclical / Execution-Driven Positioning
Medical Devices Operator
OpEx & R&D Reinvestment
15.3% of Rev ($279M)
90D Engineering Disclosures
0 Published
Investor FAQ LIVN vs ITGR Key Questions & Quantitative Answers
As of Nov 19, 2026, LivaNova PLC (LIVN) is the stronger overall head-to-head candidate over Integer Holdings Corporation (ITGR) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). LIVN carries a Unified Composite Score of 38.5/100 (SELL) at $92.07 (19.5x Forward P/E, 14.3% operating margin), whereas ITGR carries 65.5/100 (BUY) at $126.97 (18.5x Forward P/E, 9.8% operating margin). Composite vs. Pillar Nuance: While ITGR currently prints a higher short-term Unified Composite Score (65.5/100 BUY vs. LIVN 38.5/100 SELL), LIVN captures the overall institutional head-to-head verdict (6–4 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (14.3% vs. 9.8% operating margin) and revenue trajectory (+9.9% vs. -3.9% YoY).
LIVN leads the Growth & Scale pillar: LIVN posts +9.9% YoY revenue growth and -78.2% YoY earnings growth on $1.51B TTM revenue (67.6% gross margin, 14.3% operating margin), compared with ITGR at -3.9% YoY revenue growth and -61.3% YoY earnings growth on $1.83B TTM revenue (25.1% gross margin, 9.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), LIVN cumulative revenue shifted +25.2% while ITGR shifted +51.6%. In operating R&D and SG&A reinvestment, LIVN deploys 53.3% of Rev ($803M) (0 90-day corporate R&D disclosures) versus 15.3% of Rev ($279M) (0 disclosures) for ITGR.
LIVN screens cheaper on headline valuation multiples. LIVN trades at 19.5x Forward P/E, 26.5x Trailing P/E, 0.93x PEG, and 3.2x EV/Revenue (8.6% FCF margin), whereas ITGR trades at 18.5x Forward P/E, 42.5x Trailing P/E, 3.06x PEG, and 3.1x EV/Revenue (4.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against LIVN (15.5% ROE) versus ITGR (6.0% ROE) capital efficiency.
In options market volatility and institutional positioning, LIVN carries 36.9% implied volatility (11th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.98β · 67% Vol realized risk). By comparison, ITGR carries 0.7% implied volatility (<1st %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.53β · 2% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
ITGR vs LIVN · Reverse Pair
LIVN vs CNMD
· Sector Peer
LIVN vs SGRY
· Sector Peer
LIVN vs ICUI
· Sector Peer
ITGR vs CNMD
· Sector Peer
ITGR vs GKOS
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem